Head of Investor Relations
Elanco Animal Health Inc (ELAN)Equibles does not estimate personal net worth.
Get an email with a short summary when Elanco Animal Health Inc publishes a filing, an earnings call transcript or a press release.
Get ELAN alertsKaty Grissom is recorded as Head of Investor Relations at Elanco Animal Health Inc (ELAN). Katy Grissom has spoken on 11 earnings calls across 1 company, most recently for Elanco Animal Health Inc on November 7, 2024. Elanco Animal Health Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Elanco Animal Health Inc includes Jeffrey N. Simmons (CEO and Board Member), Jeffrey Simmons (CEO and Board Member), Robert (Bob) VanHimbergen (CFO) and 7 others.
“Joining us on today's call are Jeff Simmons, our President and Chief Executive Officer, Todd Young, our Chief Financial Officer, and Beth Heaney from Investor Relations.”
“Joining me on today's call are Jeff Simmons, our President and Chief Executive Officer; Todd Young, our Chief Financial Officer; and Scott Purucker from Investor Relations.”
“Joining me on the call today are Jeff Simmons, our President and Chief Executive Officer; Todd Young, our Chief Financial Officer; and Scott Purucker from Investor Relations.”
“Thank you for joining us for Elanco Animal Health’s fourth quarter and full year 2023 earnings call. I’m Katy Grissom, Head of Investor Relations. Joining me on today’s call are Jeff Simmons, our President and Chief Executive Officer, Todd Young, our Chief Financial Officer, and Scott Purucker from Investor Relations.”
“Joining me on today's call are Jeff Simmons, our President and Chief Executive Officer; Todd Young, our Chief Financial Officer; and Scott Purucker, from Investor Relations.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
